Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting
November 29, 2022 09:00 ET
|
InSilico Medicine
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the 41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
J.P. Morgan Private Bank to be Presenting Sponsor for the Audrain Tour d’Elegance
August 05, 2022 15:52 ET
|
Audrain Concours Foundation
Newport, Rhode Island, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The Audrain Newport Concours & Motor Week is pleased to announce that J.P. Morgan Private Bank has secured the exclusive naming rights as...
Financial Solutions Lab Announces 2022 Accelerator Cohort Focused on Access and Removing Systemic Barriers to Financial Benefits & Tools for Underserved Consumers
May 03, 2022 08:00 ET
|
Financial Health Network
Chicago, IL, May 03, 2022 (GLOBE NEWSWIRE) -- The Financial Solutions Lab, an initiative launched and managed by the Financial Health Network in collaboration with founding partner JPMorgan Chase...
Abel Noser Solutions Teams Up With Neovest to Provide Reporting Options for Traders, Managers and Brokers
March 29, 2022 06:30 ET
|
Abel Noser Solutions
New York, NY, March 29, 2022 (GLOBE NEWSWIRE) -- Abel Noser Solutions announced today that Abel Noser has teamed up with Neovest to create a specialized analytics reporting offering for clients and...
Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference
January 11, 2022 14:15 ET
|
Revolution Medicines, Inc.
RAS(ON) Inhibitor Pipeline Expands with Advancement of Two New Drug Candidates; Development-Stage Portfolio Covers RAS Drivers of Majority of RAS-Addicted Cancers First Patient Dosed in Global Phase...
ImCheck to Present at 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022 06:00 ET
|
ImCheck Therapeutics SAS
ImCheck to Present at 40th Annual J.P. Morgan Healthcare Conference Marseille, France, January 6, 2022 – ImCheck Therapeutics announced today that its Chief Executive Officer, Pierre...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Virtual 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 16:15 ET
|
Mettler-Toledo, LLC
Columbus, OH, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Virtual 40th Annual J.P. Morgan Healthcare...
Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies for RAS-addicted...
ATTENTION NORTHSTAR FINANCIAL SERVICES (BERMUDA) INVESTORS: The Securities Arbitration Law Firm of KlaymanToskes Commences Investigation of Potential Claims on Behalf of J.P. MORGAN SECURITIES CUSTOMERS
August 02, 2021 16:58 ET
|
Klayman & Toskes P.A.
MIAMI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- National investor fraud law firm, KlaymanToskes (“KT”), has commenced an investigation of potential FINRA arbitration claims on behalf of investors who...
Phillips Edison & Company Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
August 02, 2021 16:15 ET
|
Phillips Edison & Company, Inc.
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of omni-channel grocery-anchored...